News record
Moderna's Personalized mRNA Cancer Vaccine Succeeds in Phase 3 Melanoma Trial
Evidence state
developing
A Moderna or Merck press release with Phase 3 melanoma vaccine results and trial identifiers, plus registered-outlet coverage that directly cites the primary document.
Receipts
- captured headline
Moderna's Personalized mRNA Cancer Vaccine Succeeds in Phase 3 Melanoma Trial
- screenshot timestamp
screenshot timestamp
This page is a source-linked record. It does not score a person, infer motive, or replace the preserved source material.